Company intelligence / Profile preview

ZyMōt Fertility

Gaithersburg, Maryland, USA

Ownership: Private
Development stage: Other

Overview

ZyMōt Sperm Separation Devices have shown superiority over traditional methods like density gradient centrifugation, with improved ongoing pregnancy rates (e.g., 15% vs 9% for IUI[3]), increased fertilization rates (e.g., 83% vs 75% in a study of 3600 oocytes[5]), higher euploid embryo rates, and reduced DNA fragmentation[3][5].

Therapeutic areas: Women's HealthMen's Health
Modalities: DeviceMicrofluidic sperm sorting
Industry: Therapeutic Medical Devices

Partnerships

Collaborations with fertility centers and clinics globally (e.g., The Fertility & IVF Center of Miami, Care Fertility)[5][8]

Beyond the preview

Go deeper on ZyMōt Fertility.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ZyMōt Fertility.

Explore the full profile